Clelia Casartelli

Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study

Sara Pilotto, Antônio Rossi, Tiziana Vavalà et al. · Clinical Lung Cancer · 2017 · 46 citations

Medicine, Oncology, Molecular Oncology +9

Second Line Therapy with Weekly Low-dose Docetaxel for Pretreated Non-Small-Cell Lung Carcinoma Patients: A Multicenter Italian Phase II Study

Antonio Ardizzoia, Mirko Acquati, Daniele Fagnani et al. · Lung · 2004 · 18 citations

Medicine, Oncology, Pharmacology +11

BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients

Tiziana Vavalà, Alessandro Follador, Marcello Tiseo et al. · Lung Cancer · 2016 · 16 citations · Full text

Medicine, Oncology, Pharmacology +14

Italian multicenter survey to evaluate the opinion of patients and their reference clinicians on the "tolerance" to targeted therapies already available for non-small cell lung cancer treatment in daily clinical practice.

Silvia Novello, Enrica Capelletto, Diego Cortinovis et al. · PubMed · 2014 · 15 citations · Full text

Medicine, Oncology, Pharmacology +15

Granulocyte colony-stimulating factors used in clinical practice: PoloNord Registry-Based Cohort Italian Study.

Daniele Fagnani, P. Nova, Clelia Casartelli et al. · PubMed · 2014 · 14 citations

Medicine, Oncology, Pharmacology +13